Table 1.
Baseline characteristic of pulmonary hypertension (PH) flight patients.
| PH flight patients (N = 60) | |
|---|---|
| Age (years) | |
| Mean (SD) | 56.3 (15.7) |
| N | 60 |
| Median [Q1, Q3] | 56.5 [43.8, 66.5] |
| Gender (N, %) | |
| Male | 15 (25%) |
| Female | 45 (75%) |
| PH group (N, %) | |
| 1 | 42 (70%) |
| 2 | 3 (5%) |
| 3 | 0 (0%) |
| 4 | 14 (23%) |
| 5 | 0 (0%) |
| NA | 1 (2%) |
| Oxygen therapy | |
| No | 50 (83.3%) |
| WHO functional class | |
| I | 6 (10%) |
| II | 25 (42%) |
| III | 14 (23%) |
| IV | 1 (2%) |
| NA | 14 (23%) |
| mPAP (mmHg) | |
| Mean (SD) | 30.8 (17.5) |
| N | 40 |
| Median [Q1, Q3] | 33.5 [25.0, 39.2] |
| Cardiac index (l/min/m2) | |
| Mean (SD) | 2.80 (1.02) |
| N | 41 |
| Median [Q1, Q3] | 2.79 [2.47, 3.40] |
| PVR (dyn) | |
| Mean (SD) | 397 (303) |
| N | 41 |
| Median [Q1, Q3] | 347 [157, 568] |
| BNP (pg/mL) | |
| Mean (SD) | 94 (221) |
| N | 37 |
| Median [Q1, Q3] | 34 [11, 91] |
| 6MWD, (m/6 min) | |
| Mean (SD) | 306 (267) |
| N | 40 |
| Median [Q1, Q3] | 451 [31, 563] |
| ESC/ERS score (N, %) | |
| Low risk | 17 (28%) |
| Intermediate risk | 22 (37%) |
| High risk | 0 (0%) |
| NA | 21 (35%) |
Abbreviations: 6MWD, 6‐min walking distance; BNP, B‐type natriuretic peptide; ERS, European Respiratory Society; ESC, European Society of Cardiology; mPAP, mean pulmonary arterial pressure; PVR, pulmonary vascular resistance; SD, standard deviation; WHO, World Health Organization.